Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q4FY25 of ₹1,170.00 Crores up from ₹1,054.00 Crore year on year, a rise of 11.01%.
Total Expenses for Q4FY25 of ₹919.00 Crores up from ₹812.00 Crores year on year, a rise of 13.18%.
Consolidated Net Profit of ₹225.00 Crores up 10.84% from ₹203.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹18.03, up 13.97% from ₹15.82 in the same quarter of the previous year.